Evidence map›Paper›PMID 35647650›Full record

ArticleAntimicrobial agents and chemotherapy2022

Deletion of

Mingcong Chen, Guowei Zhong, Sha Wang, Peiying Chen, Lei Li

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mingcong Chen *Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Guowei Zhong *Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.ORCID 0000-0003-1215-1052
Sha WangKey Laboratory of Vector Biology and Pathogen Control of Zhejiang Province, Huzhou Universitygrid.411440.4, Huzhou Central Hospital, Huzhou, China.
Peiying ChenSchool of Medicine and Life Science, Nanjing University of Chinese Medicine, Nanjing, China.
Lei LiCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNHuzhou University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Aspergillus fumigatus, the most prevalent resistance to azoles results from mutational modifications of the azole target protein Cyp51A, but there are non-

Indexed as

Aspergillus fumigatusAzolesAntifungal AgentsCytochrome P-450 Enzyme SystemDrug Resistance, FungalElectron Transport Complex IVErgosterolFungal ProteinsHemeHumansItraconazoleMicrobial Sensitivity TestsNuclear ProteinsAntifungal AgentsAzolesCOX7C protein, humanCytochrome P-450 Enzyme SystemElectron Transport Complex IVErgosterolFungal ProteinsHemeItraconazoleNuclear Proteinsantifungal resistanceAspergillus fumigatuscytochrome c oxidasehemereactive oxygen species

Identifiers

PMID35647650
PMCPMC9211413
OpenAlexW4281758315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.